4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-18-048503
Director bought 6,600 shares at $15.00 ($98,985)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tullman Stephen A. Director | 2018-08-23 | Purchase | +6,600 | $15.00 | $98,985 | 170,357 | D |
| Open-market purchases · 6,600 sh · avg $15.00 · $98,985 | |||||||
Loading xslF345X03/doc4.xml…